March 19, 2020 / 6:13 AM / 15 days ago

BRIEF-Idorsia: Janssen Submits New Drug Application To FDA

March 19 (Reuters) - IDORSIA LTD:

* JANSSEN ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION TO THE U.S. FDA FOR PONESIMOD FOR TREATMENT OF ADULTS WITH RELAPSING MULTIPLE SCLEROSIS

* IDORSIA LTD - NEW DRUG APPLICATION (NDA) BASED ON DATA FROM HEAD-TO-HEAD OPTIMUM PHASE 3 STUDY Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below